Please assess the completion status of the following clinical trial:

Trial Title: Vaccination Response in ImmunoCompromised Host. Immune Response After Vaccination Against Pandemic A/H1N1 Influenza

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Above 18 years of age~* Stable antiretroviral regimen or not yet in need of treatment (in case of HIV-infected patients)~Exclusion Criteria:~* Use of systemic immunosuppressive medication~* An ongoing infection~* Recent flu-like symptoms and pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Healthy volunteers (Type: None): Healthy subjects without HIV, vaccinated with Pandemic Influenza A/H1N1
- HIV-infected patients (Type: None): HIV-infected patients, vaccinated with Pandemic Influenza A/H1N1

Based on this trial design, predict the completion outcome and termination type (if applicable).